Back
Janux Therapeutics Stock Price Chart

7 Stocks to Consider Immediately (must-see chart)
See the green days for 7 major stocks right here, free of charge
Buy
74
JANX
Janux Therapeutics
Last Price:
$26.16
Seasonality Move:
-0.89%
7 Day Trial
ALL ACCESS PASS
$
7

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JANX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Janux Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.92 | Buy |
20-day SMA: | 23.98 | Buy |
50-day SMA: | 24.99 | Buy |
200-day SMA: | 38.87 | Sell |
8-day EMA: | 18.26 | Buy |
20-day EMA: | 10.02 | Buy |
50-day EMA: | 4.6 | Buy |
200-day EMA: | 1.24 | Buy |
Janux Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 6.31 | Buy |
Relative Strength Index (14 RSI): | 60.31 | Buy |
Chaikin Money Flow: | 647159 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.18 - 25.54) | Buy |
Bollinger Bands (100): | (24.02 - 31.58) | Sell |
Janux Therapeutics Technical Analysis
Jun 30 | Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
30 | 01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Janux Therapeutics Stock
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 26.18 while JANX 8-day simple moving average is 24.92, which is a Buy signal.
-
The stock price of JANX is 26.18 while Janux Therapeutics 20-day SMA is 23.98, which makes it a Buy.
-
Janux Therapeutics 50-day simple moving average is 24.99 while JANX share price is 26.18, making it a Buy technically.
-
JANX stock price is 26.18 and Janux Therapeutics 200-day simple moving average is 38.87, creating a Sell signal.
JANX Technical Analysis vs Fundamental Analysis
Buy
74
Janux Therapeutics (JANX)
is a Buy
Is Janux Therapeutics a Buy or a Sell?
-
Janux Therapeutics stock is rated a BuyThe current Janux Therapeutics [JANX] share price is $26.18. The Score for JANX is 74, which is 48% above its historic median score of 50, and infers lower risk than normal.
Janux Therapeutics Stock Info
Market Cap:
1.5B
Price in USD:
26.18
Share Volume:
879.5K
Janux Therapeutics 52-Week Range
52-Week High:
71.71
52-Week Low:
22.48
Buy
74
Janux Therapeutics (JANX)
is a Buy
Janux Therapeutics Share Price Forecast
-
What is the Janux Therapeutics stock price today?The Janux Therapeutics stock price is 26.18 USD today.
-
Will JANX stock go up or go down?Janux Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Janux Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Janux Therapeutics is not overvalued.
Is Janux Therapeutics Stock a Buy?
-
Janux Therapeutics share price is 26.18 while JANX 8-day exponential moving average is 18.26, which is a Buy signal.
-
The stock price of JANX is 26.18 while Janux Therapeutics 20-day EMA is 10.02, which makes it a Buy.
-
Janux Therapeutics 50-day exponential moving average is 4.60 while JANX share price is 26.18, making it a Buy technically.
-
JANX stock price is 26.18 and Janux Therapeutics 200-day simple moving average is 1.24, creating a Buy signal.
Fundamental Analysis of Janux Therapeutics
Is Janux Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.30 per share, a decrease this year of $0.81 per share, and a decrease next year of $0.71 per share.
Technical Analysis of Janux Therapeutics
Should I short Janux Therapeutics stock?
-
JANX Moving Average Covergence Divergence (MACD) indicator is 6.31, suggesting Janux Therapeutics is a Buy
-
Janux Therapeutics Relative Strength Index (RSI) is 60.31, which suggest Janux Therapeutics is overbought
-
The Bollinger Bands (25) for Janux Therapeutics is (23.18 - 25.54), which suggest Janux Therapeutics is a Sell
-
The Bollinger Bands (100) for Janux Therapeutics is (24.02 - 31.58), which suggest Janux Therapeutics is a Sell
* Janux Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.